NL-OMON29599招募中不适用
Treatment of severe acute GVHD after allogeneic hematopoietic stem celltransplantation with steroids versus MSC and steroids.A prospective double-blind placebo-controlled randomized phase III trial
HOVON Data Center0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •- Previously treated with allo-SCT/ DLI;
排除标准
- •- Patients with active, uncontrolled infection;
- •- Rapid progressive hematological malignancy;
研究者
相似试验
招募中
3 期
Treatment of severe acute GVHD after allogeneic hematopoietic stem cell transplantation with steroids versus MSC and steroids. A prospective double-blind placebo-controlled randomized phase III trialstamceltransplantatie gerelateerde complicatie: Graft versus Host ziekteGraft versus Host Disease10018849NL-OMON41587HOVO140
进行中（未招募）
不适用
Treatment of severe acute GVHD after allogeneic hematopoietic stem cell transplantation with steroids versus MSC and steroids.A prospective double-blind placebo-controlled randomized phase III trialGraft Versus Host DiseaseMedDRA version: 18.0Level: PTClassification code 10066260Term: Acute graft versus host diseaseSystem Organ Class: 10021428 - Immune system disordersMedDRA version: 18.0Level: LLTClassification code 10068908Term: AGVHDSystem Organ Class: 10021428 - Immune system disordersEUCTR2011-003237-33-NLHOVON Foundation200
招募中
不适用
Prevention of severe GVHD after allogeneic hematopoietic stem cell transplantation, applied as consolidation immunotherapy in patients with hematological malignancies. A prospective randomized phase III trial.Randomization 1: Patients planned to undergo an allogeneic SCT formalignant hematological disorders and with a related or unrelated 8/8 HLA matched donor.NL-OMON28315Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC - Daniel den HoedPostbus 52013008 AE RotterdamTel: 010 7041560Fax: 010 7041028e-mail: hdc@erasmusmc.nl500
进行中（未招募）
1 期
Preventie van ernstige Graft versus Host ziekte na allogene stamcel transplantatie gegeven als immuuntherapie voor patienten met een hematologische ziekte. Een gerandomiseerde fase III studie (HOVON 96 GVHD).Graft versus Host DiseaseMedDRA version: 20.0Level: LLTClassification code 10018799Term: GVHDSystem Organ Class: 100000004870EUCTR2008-003540-11-NLHOVON Foundation500
已完成
3 期
Prevention of severe GVHD after allogeneic hematopoietic stem cell transplantation, applied as consolidation immunotherapy in patients with hematological malignancies. A prospective randomized phase III trial.Graft versus Host Disease10018849NL-OMON47822HOVO497